Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion type Assertion NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_head.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion description "[After 24weeks of treatment, percentages of IFN?-induced pSTAT1+ and IL-10-induced pSTAT3+ monocytes in RA patients increased, reaching levels comparable to HDs. pSTAT1+ and pSTAT3+ cells correlated inversely with RA disease activity index and levels of pSTAT+ cells at baseline were higher in patients with good EULAR response to tocilizumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_provenance.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion evidence source_evidence_literature NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_provenance.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion SIO_000772 25847223 NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_provenance.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion wasDerivedFrom befree-2016 NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_provenance.
- NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_assertion wasGeneratedBy ECO_0000203 NP1276217.RAiw5P9PyV11IVu4898NJksK9qmnPiW0RqO5-hVLsEx6Q130_provenance.